Fernández-Metzler C - Search Results

1

Biomarker Assay Validation by Mass Spectrometry.

Fernández-Metzler C, Ackermann B, Garofolo F, Arnold ME, DeSilva B, Gu H, Laterza O, Mao Y, Rose M, Vazvaei-Smith F, Steenwyk R. Fernández-Metzler C, et al. AAPS J. 2022 May 9;24(3):66. doi: 10.1208/s12248-022-00707-z. AAPS J. 2022. PMID: 35534647

2

Is Incurred Sample Reanalysis (ISR) Applicable in Biomarker Assays?

Hays A, Amaravadi L, Fernandez-Metzler C, King L, Mathews J, Ni Y, Quadrini K, Tinder C, Vazvaei F, Zeng J. Hays A, et al. Among authors: fernandez metzler c. AAPS J. 2022 May 5;24(3):65. doi: 10.1208/s12248-022-00708-y. AAPS J. 2022. PMID: 35511303 No abstract available.

3

Determination of potato carboxypeptidase inhibitor in African Green Monkey plasma using 96-well SPE and LC-MS/MS.

Rose MJ, Fernandez-Metzler C, Johns BA, Sitko GR, Cook JJ, Yergey J. Rose MJ, et al. J Pharm Biomed Anal. 2005 Jul 15;38(4):695-702. doi: 10.1016/j.jpba.2004.09.059. Epub 2005 Mar 21. J Pharm Biomed Anal. 2005. PMID: 15967297

4

Determination of chiral sulfoxides in plasma by normal-phase liquid chromatography-atmospheric pressure chemical ionization mass spectrometry.

Miller-Stein C, Fernandez-Metzler C. Miller-Stein C, et al. J Chromatogr A. 2002 Jul 26;964(1-2):161-8. doi: 10.1016/s0021-9673(02)00667-2. J Chromatogr A. 2002. PMID: 12198844

5

Applications of low-flow LC-SRM for the analysis of large molecules in pharmaceutical R&D.

Lassman ME, Fernandez-Metzler C. Lassman ME, et al. Among authors: fernandez metzler c. Bioanalysis. 2014;6(13):1859-67. doi: 10.4155/bio.14.141. Bioanalysis. 2014. PMID: 25157490 Review.

6

Rapid liquid chromatography with tandem mass spectrometry-based screening procedures for studies on the biotransformation of drug candidates.

Fernández-Metzler CL, Owens KG, Baillie TA, King RC. Fernández-Metzler CL, et al. Drug Metab Dispos. 1999 Jan;27(1):32-40. Drug Metab Dispos. 1999. PMID: 10068285

7

The development and cross-validation of methods based on radioimmunoassay and LC/MS-MS for the quantification of the class III antiarrhythmic agent, MK-0499, in human plasma and urine.

Gilbert JD, Greber TF, Ellis JD, Barrish A, Olah TV, Fernández-Metzler C, Yuan AS, Burke CJ. Gilbert JD, et al. J Pharm Biomed Anal. 1995 Jul;13(8):937-50. doi: 10.1016/0731-7085(95)01540-2. J Pharm Biomed Anal. 1995. PMID: 8580153

8

Negative ion tandem mass spectrometry for the detection of glutathione conjugates.

Dieckhaus CM, Fernández-Metzler CL, King R, Krolikowski PH, Baillie TA. Dieckhaus CM, et al. Chem Res Toxicol. 2005 Apr;18(4):630-8. doi: 10.1021/tx049741u. Chem Res Toxicol. 2005. PMID: 15833023

9

The use of Qtrap technology in drug metabolism.

King R, Fernandez-Metzler C. King R, et al. Curr Drug Metab. 2006 Jun;7(5):541-5. doi: 10.2174/138920006777697936. Curr Drug Metab. 2006. PMID: 16787161 Review.

10

Collection of selected reaction monitoring and full scan data on a time scale suitable for target compound quantitative analysis by liquid chromatography/tandem mass spectrometry.

King RC, Gundersdorf R, Fernández-Metzler CL. King RC, et al. Rapid Commun Mass Spectrom. 2003;17(21):2413-22. doi: 10.1002/rcm.1214. Rapid Commun Mass Spectrom. 2003. PMID: 14587088

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

33 results

Search Page